Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Neuromyelitis Optica Spectrum Disorder
Related studies linked through entity extraction aliases.
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Biomarkers in Autoimmune Disease of Nervous System
- Status
- RECRUITING
- Phase
- N/A
FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
- Status
- RECRUITING
- Phase
- NA
Acceptability and Safety of MR-C-014 in Persons With Neuromyelitis Optica Spectrum Disorder
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Long-term, Open-label, Safety Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
- Status
- RECRUITING
- Phase
- N/A
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
- Status
- RECRUITING
- Phase
- N/A
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
- Status
- RECRUITING
- Phase
- N/A
Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
- Status
- RECRUITING
- Phase
- PHASE2
Ofatumumab in AQP4-IgG Seropositive NMOSD
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
- Status
- UNKNOWN
- Phase
- NA